After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Apellis Pharmaceuticals Inc is $2.75B. A total of 2.21 million shares were traded on the day, compared to an average of 2.81M shares.
In the most recent transaction, Baumal Caroline sold 2,797 shares of APLS for 21.77 per share on Jan 22 ’26. After the transaction, the Chief Medical Officer now owns 86,527 company shares. In a previous transaction on Jan 22 ’26, Chopas James George sold 2,064 shares at 21.77 per share. APLS shares that VP/Chief Accounting Officer owns now total 49,805.
Among the insiders who sold shares, DeLong Mark Jeffrey disposed of 3,371 shares on Jan 22 ’26 at a per-share price of $21.77. This resulted in the Chief Business & Strat Officer holding 78,353 shares of APLS after the transaction. In another insider transaction, Deschatelets Pascal sold 5,928 shares at $21.77 per share on Jan 22 ’26. Company shares held by the Chief Scientific Officer now total 1,151,382.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, APLS has a high of $31.17 and a low of $16.10.
As of this writing, APLS has an earnings estimate of -$0.39 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.16 per share and a lower estimate of -$0.55. The company reported an EPS of -$0.29 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. APLS’s latest balance sheet shows that the firm has $700.55M in Cash & Short Term Investments as of fiscal 2021. There were $210.22M in debt and $131.85M in liabilities at the time. Its Book Value Per Share was $3.17, while its Total Shareholder’s Equity was $198.66M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
